These findings are not surprising, since TP53 and ATM function are involved in maintaining genomic stability [66–67], and the U-IGHV configuration identifies a CLL clone that is responsive to B-cell receptor antigen stimulation with consequent cell activation [40–41]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.